Stock Comparison

BIIB vs LLY

Biogen Inc and Eli Lilly and Company side by side — valuation, profitability, growth and risk.

BIIB

Biogen Inc

Healthcare

LLY

Eli Lilly and Company

Healthcare

Valuation

Market Cap

$31.25B

$1.04T

P/E (TTM)

37.5

39.1

Forward P/E

17.3

32.1

Price/Sales

3.1

13.0

Price/Book

1.7

30.6

EV/EBITDA

17.8

26.0

Dividend Yield

—

0.53%

Profitability

Net Margin

8.39%

33.53%

Operating Margin

12.79%

43.92%

Return on Equity

4.58%

102.30%

Return on Assets

5.21%

20.40%

Growth (YoY)

Revenue Growth

3.40%

47.70%

Earnings Growth

-84.80%

26.20%

Price & Risk

Beta

0.2

0.5

52-Week High

$216.63

$1,235.65

52-Week Low

$132.22

$679.67

Analyst Target

$235.32

$1,297.31

Compare BIIB and LLY your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.